TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive NCI “Community Cancer Centers” Program in Development, House Report Reveals. June 30, 2006
TCL Archive CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell November 12, 1976
